USANA Health Sciences (USNA) Stock Price, News & Analysis

Company Overview

USANA Health Sciences, Inc. develops and sells nutritional supplements, healthy foods and personal-care products through a direct-selling business model. Its product portfolio includes vitamins and mineral supplements, meal-replacement and snack products, sports nutrition offerings, and skincare products marketed under the USANA and related brands.

Founded in 1992 by microbiologist and immunologist Myron W. Wentz, the company is headquartered in Salt Lake City, Utah. USANA distributes its products through a network of independent associates and preferred customers rather than primarily through traditional retail channels.

The company serves customers in markets across the Americas, Asia-Pacific and Europe, with a significant presence in countries including the United States, Canada, Australia, New Zealand, China, Hong Kong, Japan, South Korea, the Philippines, Singapore, Malaysia and Thailand. Jim Brown serves as USANA’s president and chief executive officer.

Key Stats

• Today's Range: $13.85 to $14.24
• 50-Day Range: $13.18 to $15.48
• 52-Week Range: $12.57 to $23.59
• Volume: 136,748 shs
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Reduce

USANA Health Sciences Stock Analysis - MarketRank™

USANA Health Sciences scored higher than 20% of companies evaluated by MarketBeat, and ranked 145th out of 170 stocks in the consumer staples sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.2 / 5
• Analyst Rating: Reduce

Consensus Rating

USANA Health Sciences has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and 1 sell rating.

Amount of Analyst Coverage

USANA Health Sciences has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 132.89%

Earnings Growth

Earnings for USANA Health Sciences are expected to grow by 132.89% in the coming year, from $0.76 to $1.77 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of USANA Health Sciences is -11.57, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of USANA Health Sciences is -11.57, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

4.25% of the float of USANA Health Sciences has been sold short.

Short Interest Ratio / Days to Cover

USANA Health Sciences has a short interest ratio ("days to cover") of 4.43.

Change versus previous month

Short interest in USANA Health Sciences has recently increased by 0.97%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

USANA Health Sciences does not currently pay a dividend.

Dividend Growth

USANA Health Sciences does not have a long track record of dividend growth.

News and Social Media

• Score: 1.5 / 5
• News Sentiment: 0.32

News Sentiment

USANA Health Sciences has a news sentiment score of 0.32. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.58 average news sentiment score of Consumer Staples companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for USANA Health Sciences this week, compared to 2 articles on an average week.

MarketBeat Follows

Only 1 people have added USANA Health Sciences to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 0.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, USANA Health Sciences insiders have not sold or bought any company stock.

Percentage Held by Insiders

0.82% of the stock of USANA Health Sciences is held by insiders.

Percentage Held by Institutions

54.25% of the stock of USANA Health Sciences is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/04/2026
• Today: 10/27/2026
• Next Earnings (Confirmed): 11/03/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Consumer Staples
• Industry: Personal Care Products
• Sub-Industry: Personal Care Products
• Current Symbol: NYSE:USNA
• CIK: 896264
• Web: www.usana.com
• Phone: (801) 954-7100
• Fax: 801-954-7300
• Employees: 1,570
• Year Founded: 1992

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 18.42
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: 18,325,000
• Market Cap: N/A
• Optionable: Optionable
• Beta: N/A